Oncology Central
  • Home
  • News
  • Insights
    • Insights
      • Opinion
      • Columnists
      • Journal articles
      • Events
      • Spotlights
      • In focus
      • Follow us on social media
    • ADVERT
  • Topics
    • Disease area
      • Skin
      • Breast
      • Colorectal
      • Hematologic
      • Lung
      • View all
      • Follow us on social media
    • Subject area
      • Immuno-oncology
      • Clinical trials
      • Genetics
      • Preclinical research and trials
      • Prevention and screening
      • Therapies
      • View all
    • ADVERT
  • Multimedia
    • Multimedia
      • Videos
      • Podcasts
      • Infographics
      • Webinars
      • Follow us on social media
    • ADVERT
  • Register
  • i
  • i
  • i
  • Home
  • News
  • Insights
    • Opinion
    • Columnists
    • Journal articles
    • Spotlights
    • In Focus
    • Events
  • Topics
    • Disease area
      • Skin
      • Breast
      • Colorectal
      • Hematologic
      • Lung
      • View all
    • Subject area
      • Immuno-oncology
      • Clinical trials
      • View all
  • Multimedia
    • Videos
    • Infographics
    • Podcasts
    • Webinars
  • Registration
  • Follow us on social media
  • i
  • i

Login

Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.

Forgot your password?

Or register via social media

Already have an account? Login here

Or register via social media

Already have an account? Login here

Most searched
  • ask the experts
  • aacr
  • asco
  • IMpower150
  • research

progression-free survival

  • 25 May 2018 Lung

    Imfinzi® significantly improves overall survival in Phase III PACIFIC trial

  • 26 Apr 2017 Journals

    Reduced-intensity or myeloablative allogeneic hematopoietic cell transplantation for mantle cell lymphoma: a systematic review

  • 14 Oct 2016

    ESMO16: Niraparib improves progression-free survival in recurrent ovarian cancer

  • 1 Jun 2015

    ASCO15: Ipilimumab/nivolumab combination treatment shows significant improvement in response rates for advanced melanoma

  • 6 May 2015

    Ibrutinib demonstrates continued effectiveness in Waldenström’s Macroglobulinemia

  • 30 Mar 2015

    Advanced thyroid cancer responds to targeted therapy with sunitinib

  • 21 Jan 2015

    Stereotactic body radiation therapy plus chemotherapy improves survival among stage IV lung cancer patients

  • 9 Jan 2015

    Platinum-based combination well tolerated and clinically active in metastatic triple-negative breast cancer

  • 3 Jan 2015

    Antiangiogenic therapies for glioblastoma

  • 23 Dec 2014

    mRNAs could help predict prognosis in multiple myeloma patients

  • 3 Dec 2014

    Ofatumumab as maintenance therapy for relapsed chronic lymphocytic leukemia: new data released

  • 27 Nov 2014 Journal Articles

    SIR-Spheres® radioembolization in the management of metastatic colorectal cancer: a medical oncology perspective

View More
  • About us
  • Contact Us
  • Our journals
  • Advertising & Sponsorship
  • Ambassadors
  • Twitter
  • Facebook
  • Linkedin
  • RSS
  • Oncology Central Newsletter

    Like our content? Subscribe to our weekly newsletter for news & articles direct to your inbox.


    Stay connected
    • Twitter
    • Facebook
    • Linkedin
    • RSS
  • Find a job

    Connecting talent with opportunity, have a look at our Career Center and find your ideal next career move.

    Registration

    When you create your free account, you will be able to view all articles in full and see content personally tailored for you. Register here.

    Office Info

    Oncology Central is powered by Future Science Group.
    Unitec House, 2 Albert Place, London, N3 1QB, UK,
    +44 (0)20 8371 6090

    • About us
    • Contact Us
    • Our journals
    • Advertising & Sponsorship
    • Ambassadors
    • Find a job

      Connecting talent with opportunity, have a look at our Career Center and find your ideal next career move.

      Registration

      When you create your free account, you will be able to view all articles in full and see content personally tailored for you. Register here.

      Office Info

      Oncology Central is powered by Future Science Group.
      Unitec House, 2 Albert Place, London, N3 1QB, UK,
      +44 (0)20 8371 6090

  • Future Science Group
  • Cookies Policy
  • Privacy Policy
  • Terms & Conditions
  • ©2019 Oncology Central
© 2018 Oncology Central